These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 20064935)

  • 1. Nuclear aggregation of polyglutamine-expanded ataxin-3: fragments escape the cytoplasmic quality control.
    Breuer P; Haacke A; Evert BO; Wüllner U
    J Biol Chem; 2010 Feb; 285(9):6532-7. PubMed ID: 20064935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recruitment and the role of nuclear localization in polyglutamine-mediated aggregation.
    Perez MK; Paulson HL; Pendse SJ; Saionz SJ; Bonini NM; Pittman RN
    J Cell Biol; 1998 Dec; 143(6):1457-70. PubMed ID: 9852144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calpain inhibition is sufficient to suppress aggregation of polyglutamine-expanded ataxin-3.
    Haacke A; Hartl FU; Breuer P
    J Biol Chem; 2007 Jun; 282(26):18851-6. PubMed ID: 17488727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteolytic cleavage of polyglutamine-expanded ataxin-3 is critical for aggregation and sequestration of non-expanded ataxin-3.
    Haacke A; Broadley SA; Boteva R; Tzvetkov N; Hartl FU; Breuer P
    Hum Mol Genet; 2006 Feb; 15(4):555-68. PubMed ID: 16407371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro.
    Chai Y; Koppenhafer SL; Shoesmith SJ; Perez MK; Paulson HL
    Hum Mol Genet; 1999 Apr; 8(4):673-82. PubMed ID: 10072437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleocytoplasmic shuttling activity of ataxin-3.
    Macedo-Ribeiro S; Cortes L; Maciel P; Carvalho AL
    PLoS One; 2009 Jun; 4(6):e5834. PubMed ID: 19503814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear localization of ataxin-3 is required for the manifestation of symptoms in SCA3: in vivo evidence.
    Bichelmeier U; Schmidt T; Hübener J; Boy J; Rüttiger L; Häbig K; Poths S; Bonin M; Knipper M; Schmidt WJ; Wilbertz J; Wolburg H; Laccone F; Riess O
    J Neurosci; 2007 Jul; 27(28):7418-28. PubMed ID: 17626202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caspase-mediated proteolysis of the polyglutamine disease protein ataxin-3.
    Berke SJ; Schmied FA; Brunt ER; Ellerby LM; Paulson HL
    J Neurochem; 2004 May; 89(4):908-18. PubMed ID: 15140190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ataxin-3 is translocated into the nucleus for the formation of intranuclear inclusions in normal and Machado-Joseph disease brains.
    Fujigasaki H; Uchihara T; Koyano S; Iwabuchi K; Yagishita S; Makifuchi T; Nakamura A; Ishida K; Toru S; Hirai S; Ishikawa K; Tanabe T; Mizusawa H
    Exp Neurol; 2000 Oct; 165(2):248-56. PubMed ID: 10993685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteotoxic stress increases nuclear localization of ataxin-3.
    Reina CP; Zhong X; Pittman RN
    Hum Mol Genet; 2010 Jan; 19(2):235-49. PubMed ID: 19843543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse models of Machado-Joseph disease and other polyglutamine spinocerebellar ataxias.
    Colomer Gould VF
    NeuroRx; 2005 Jul; 2(3):480-3. PubMed ID: 16389311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CK2-dependent phosphorylation determines cellular localization and stability of ataxin-3.
    Mueller T; Breuer P; Schmitt I; Walter J; Evert BO; Wüllner U
    Hum Mol Genet; 2009 Sep; 18(17):3334-43. PubMed ID: 19542537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mutant ataxin-3 putative-cleavage fragment in brains of Machado-Joseph disease patients and transgenic mice is cytotoxic above a critical concentration.
    Goti D; Katzen SM; Mez J; Kurtis N; Kiluk J; Ben-Haïem L; Jenkins NA; Copeland NG; Kakizuka A; Sharp AH; Ross CA; Mouton PR; Colomer V
    J Neurosci; 2004 Nov; 24(45):10266-79. PubMed ID: 15537899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDK5 protects from caspase-induced Ataxin-3 cleavage and neurodegeneration.
    Liman J; Deeg S; Voigt A; Voßfeldt H; Dohm CP; Karch A; Weishaupt J; Schulz JB; Bähr M; Kermer P
    J Neurochem; 2014 Jun; 129(6):1013-23. PubMed ID: 24548080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Polyglutamine-expanded ataxin-3 is degraded by autophagy].
    Xiao H; Tang J; Hu Z; Tan J; Tang B; Jiang Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Feb; 27(1):23-8. PubMed ID: 20140862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo suppression of polyglutamine neurotoxicity by C-terminus of Hsp70-interacting protein (CHIP) supports an aggregation model of pathogenesis.
    Williams AJ; Knutson TM; Colomer Gould VF; Paulson HL
    Neurobiol Dis; 2009 Mar; 33(3):342-53. PubMed ID: 19084066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promyelocytic leukemia protein is redistributed during the formation of intranuclear inclusions independent of polyglutamine expansion: an immunohistochemical study on Marinesco bodies.
    Kumada S; Uchihara T; Hayashi M; Nakamura A; Kikuchi E; Mizutani T; Oda M
    J Neuropathol Exp Neurol; 2002 Nov; 61(11):984-91. PubMed ID: 12430715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyglutamine-induced neurodegeneration in SCA3 is not mitigated by non-expanded ataxin-3: conclusions from double-transgenic mouse models.
    Hübener J; Riess O
    Neurobiol Dis; 2010 Apr; 38(1):116-24. PubMed ID: 20079840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-expanded polyglutamine proteins in intranuclear inclusions of hereditary ataxias--triple-labeling immunofluorescence study.
    Uchihara T; Fujigasaki H; Koyano S; Nakamura A; Yagishita S; Iwabuchi K
    Acta Neuropathol; 2001 Aug; 102(2):149-52. PubMed ID: 11563629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ectoine alters subcellular localization of inclusions and reduces apoptotic cell death induced by the truncated Machado-Joseph disease gene product with an expanded polyglutamine stretch.
    Furusho K; Yoshizawa T; Shoji S
    Neurobiol Dis; 2005 Oct; 20(1):170-8. PubMed ID: 16137577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.